AHWB(301520.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
AHWB
301520.SZ
Anhui Wanbang Pharmaceutical Technology Co.,Ltd. provides pharmaceutical research and clinical research services in China. The company offers service platform for pharmaceutical research, raw materials, clinical research, medical device services, biological sample analysis, SMO service, and statistical analysis. It also provides precision nutrition cooperation and ecosystem platform; and drug platform.
595.33 B
301520.SZMarket value -Rank by Market Cap -/-

Financial Score

21/05/2026 Update
D
Life Sciences Tools and ServicesIndustry
Industry Ranking26/26
Industry medianC
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE0.00%D
    • Profit Margin0.00%D
    • Gross Margin15.25%D
  • Growth ScoreE
    • Revenue YoY-35.09%E
    • Net Profit YoY-64.07%E
    • Total Assets YoY1.57%C
    • Net Assets YoY1.20%C
  • Cash ScoreD
    • Cash Flow Margin18.80%D
    • OCF YoY-35.09%E
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreA
    • Gearing Ratio5.33%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    AHWB released its performance for the first three quarters, with a net profit attributable to the parent company of 33.1106 million yuan, a decrease of 57.44%

    Zhitong·
    SZ
    301520
    -2.92%
    Zhitong·
    SZ
    301520
    -2.92%

    The innovative drug concept fell at the beginning of the session, with Cosunter down 10%

    Zhitong·
    SZ
    002550
    -1.52%
    SZ
    000788
    -2.85%
    SZ
    301520
    -2.92%
    Zhitong·
    SZ
    002550
    -1.52%
    SZ
    000788
    -2.85%
    SZ
    301520
    -2.92%

    The medical services sector has seen a short-term decline, with Kingchem falling over 8%

    Zhitong·
    SZ
    301096
    +3.29%
    SH
    688222
    +3.23%
    SZ
    301520
    -2.92%
    Zhitong·
    SZ
    301096
    +3.29%
    SH
    688222
    +3.23%
    SZ
    301520
    -2.92%

    Ergothioneine receives attention, multiple listed companies respond to related questions

    Zhitong·
    SZ
    301371
    -2.99%
    SZ
    301520
    -2.92%
    SH
    603896
    -1.98%
    Zhitong·
    SZ
    301371
    -2.99%
    SZ
    301520
    -2.92%
    SH
    603896
    -1.98%

    AHWB released its 2024 annual performance, with a net profit attributable to the parent company of 85.5307 million yuan, a decrease of 20.87%

    Zhitong·
    SZ
    301520
    -2.92%
    Zhitong·
    SZ
    301520
    -2.92%
    © 2026 Longbridge｜Disclaimer